insights_auto
Why is ORKA down 4.89%?
Dive Deeperchevron_right
ORKA:NASDAQ
Oruka Therapeutics Inc
$89.92
arrow_downward
-4.89%(-4.62) 1D
$90.05
arrow_upward
+0.14% (+0.13)bedtimeAfter hours
Closed: Sep 23, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORKA...
Open
$94.08
High
$95.81
Low
$85.00
Mkt. cap
5.95B
Avg. vol.
860.24K
Volume
1.99M
52-wk high
$115.51
52-wk low
$14.89
EPS
-$2.46
Beta
-0.37
Shares outstanding
66.21M
No. of employees
68
Open
$94.08
High
$95.81
Low
$85.00
Mkt. cap
5.95B
Avg. vol.
860.24K
Volume
1.99M
52-wk high
$115.51
52-wk low
$14.89
EPS
-$2.46
Beta
-0.37
Shares outstanding
66.21M
No. of employees
68
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
What Oruka Therapeutics (ORKA)'s Phase 2a Psoriasis Data Means For Shareholders
marketscreener.com
·
8 hours ago
Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001
Benzinga
·
9 hours ago
10 Health Care Stocks Whale Activity In Today’s Session
Benzinga
·
12 hours ago
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy
About Oruka Therapeutics Inc
CEO-
Employees68
Founded2024
HeadquartersWestminster, Colorado, United States
SectorBiotechnology
Websiteorukatx.com